Clinical Trial Update: Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of laser treatment, ranibizumab, and triamcinolone for proliferative diabetic retinopathy has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• Lucentis (ranibizumab)

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Proliferative Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2011-07-13